These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 24413495)
41. Reporting and treating gonorrhea: results of a statewide survey in Alaska. Eisenberg MS; Wiesner PJ J Am Vener Dis Assoc; 1976 Dec; 3(2 Pt 1):79-83. PubMed ID: 1010773 [TBL] [Abstract][Full Text] [Related]
42. Antibiotic treatment for urinary tract infections does not follow guidelines, study says. Rollins G Rep Med Guidel Outcomes Res; 2002 Feb; 13(4):1-2, 5. PubMed ID: 12434774 [No Abstract] [Full Text] [Related]
43. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985 [TBL] [Abstract][Full Text] [Related]
45. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. Ramus RM; Sheffield JS; Mayfield JA; Wendel GD Am J Obstet Gynecol; 2001 Sep; 185(3):629-32. PubMed ID: 11568790 [TBL] [Abstract][Full Text] [Related]
47. The Antimicrobial Treatment Strategies (MIKSTRA) program: a 5-year follow-up of infection-specific antibiotic use in primary health care and the effect of implementation of treatment guidelines. Rautakorpi UM; Huikko S; Honkanen P; Klaukka T; Makela M; Palva E; Roine R; Sarkkinen H; Varonen H; Huovinen P; Clin Infect Dis; 2006 May; 42(9):1221-30. PubMed ID: 16586379 [TBL] [Abstract][Full Text] [Related]
48. [Questionnaire survey of guideline implementation for community acquired pneumonia with retrospective analysis of the empiric treatment in 490 patients]. Xu ZJ; Ding K; Huang H; Sun TY; Ke HX; Tong ZH; Wei TN; Peng K; Yao B; Li FX; Liu JH; ; Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):442-6. PubMed ID: 17673019 [TBL] [Abstract][Full Text] [Related]
49. An evaluation of compliance with an antibiotic policy in surgical wards at a general teaching hospital in northern ireland. Aldeyab MA; Elshibly SM; McElnay JC; Davies E; Scott MG; Magee FA; Leyden P; Kearney MP Infect Control Hosp Epidemiol; 2009 Sep; 30(9):921-2. PubMed ID: 19653821 [No Abstract] [Full Text] [Related]
50. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Golparian D; Hellmark B; Fredlund H; Unemo M Sex Transm Infect; 2010 Nov; 86(6):454-60. PubMed ID: 20940159 [TBL] [Abstract][Full Text] [Related]
51. [Do general practitioners follow the therapeutical recommendations of cystitis in women? INURA study]. Rabanaque G; López A; Cots JM; Llor C Rev Esp Quimioter; 2011 Jun; 24(2):79-83. PubMed ID: 21666999 [TBL] [Abstract][Full Text] [Related]
52. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia. Hustig A; Bell C; Waddell R Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709 [TBL] [Abstract][Full Text] [Related]
53. High frequencies of negative pretreatment results following presumptive antibiotic treatment for chlamydia and gonorrhea. Andric B; Drowos J; Trepka MJ; Suciu G; Alonso A; Hennekens CH South Med J; 2013 May; 106(5):321-6. PubMed ID: 23644641 [TBL] [Abstract][Full Text] [Related]
54. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Unemo M; Golparian D; Hestner A Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645 [TBL] [Abstract][Full Text] [Related]
55. Antibiotic policy use amongst junior doctors in a Merseyside hospital. Harnett SJ; Allen KD J Hosp Infect; 2000 Nov; 46(3):239-40. PubMed ID: 11073736 [No Abstract] [Full Text] [Related]
56. Sequential therapy for gonococci inflammation of paraurethral glands in males. Fan W; Zhang Q; Fan Z J Dermatolog Treat; 2012 Jun; 23(3):184-8. PubMed ID: 21105823 [TBL] [Abstract][Full Text] [Related]
57. Why should 1 gram of ceftriaxone monotherapy be considered as a therapeutic option in gonococcal sexually transmitted diseases? Davido B; Bouchand F; Tritz T; Makhloufi S Clin Microbiol Infect; 2016 Nov; 22(11):903-904. PubMed ID: 27404364 [No Abstract] [Full Text] [Related]
58. Immediate hypersensitivity reaction to single-dose parenteral ceftriaxone therapy for gonorrhea. Zishka PA; Douglas JM Sex Transm Dis; 1991; 18(1):26-7. PubMed ID: 2028365 [TBL] [Abstract][Full Text] [Related]
59. Lidocaine as a diluent for ceftriaxone in the treatment of gonorrhea. Does it reduce the pain of the injection? Schichor A; Bernstein B; Weinerman H; Fitzgerald J; Yordan E; Schechter N Arch Pediatr Adolesc Med; 1994 Jan; 148(1):72-5. PubMed ID: 8143016 [TBL] [Abstract][Full Text] [Related]
60. Effectiveness of Bazhengsan formula as an adjunctive therapy to ceftriaxone for female patients with uncomplicated gonorrhea: A pilot study. Li N; Li L Medicine (Baltimore); 2019 Mar; 98(9):e14679. PubMed ID: 30817597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]